Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study

BACKGROUND: Mother-to-child transmission (MTCT) cannot be completely prevented by the administration of active-passive immunoprophylaxis in pregnant women with hepatitis B virus (HBV) DNA levels <10(6) copies/mL. This study will assess the economic outcomes of expanding antiviral prophylaxis in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Jiangyang, Wang, Zhenhua, Wu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246348/
https://www.ncbi.nlm.nih.gov/pubmed/32478119
http://dx.doi.org/10.1093/ofid/ofaa137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246348/
https://www.ncbi.nlm.nih.gov/pubmed/32478119
http://dx.doi.org/10.1093/ofid/ofaa137

Ejemplares similares